Active Ingredient (In Each Capsule)
Lansoprazole 15 mg
The following Structured Product Label (SPL) was submitted to the FDA by Padagis Israel Pharmaceuticals Ltd for the product Lansoprazole (NDC 45802-878). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient (in each capsule), purpose, use, warnings, do not use if you have:, ask a doctor before use if you have, ask a doctor or pharmacist before use if you are, stop use and ask a doctor if, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Lansoprazole 15 mg
Acid Reducer
Allergy alert:
If an allergic reaction occurs, stop use and seek medical help right away.
These may be signs of a serious condition. See your doctor.
ask a health care professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).
D&C red no. 28, D&C yellow no. 10, FD&C blue no. 1, FD&C red no. 40, gelatin, hypromellose, low substituted hydroxypropyl cellulose, mannitol, meglumine, methacrylic acid copolymer, pharmaceutical ink, polyethylene glycol, polysorbate 80, sodium lauryl sulfate, sugar spheres, talc, titanium dioxide
1-800-719-9260
Compare to Prevacid® 24 HR active ingredient
Lansoprazole Delayed-Release Capsules, 15 mg
Acid Reducer
24 HR
Treats Frequent Heartburn
• May take 1 to 4 days for full effect
• Sodium Free
Actual Size
28 CAPSULES
Two 14-Day Courses of Treatment
Padagis®
* Please review the disclaimer below.